Technical Analysis for BNTX - BioNTech SE
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 78.83 | -1.90% | -1.53 |
BNTX closed down 1.9 percent on Monday, July 1, 2024, on 1.12 times normal volume. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing Low | Bearish | 0.00% | |
| Reversal New Lows Setup | Bearish Swing Setup | 0.00% | |
| Slingshot Bearish | Bearish Swing Setup | 0.00% | |
| New 52 Week Low | Weakness | 0.00% | |
| Multiple of Ten Bearish | Other | 0.00% | |
| Outside Day | Range Expansion | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Down 3 Days in a Row | Weakness | 0.00% | |
| Down 4 Days in a Row | Weakness | 0.00% | |
| Down 5 Days in a Row | Weakness | 0.00% |
| Alert | Time |
|---|---|
| Down 1% | about 8 hours ago |
| Outside Day | about 8 hours ago |
| Fell Below Previous Day's Low | about 8 hours ago |
| New 52 Week Low | about 8 hours ago |
| 60 Minute Opening Range Breakdown | about 9 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 08/05/2024
BioNTech SE focuses on the development of molecular immune therapies and biomarker-based diagnostic approaches. The firm develops and manufactures biomarker-based in vitro diagnostic devices (IVDD) and commercializes products. It offers drug discovery services for therapeutic areas including infectious diseases, allergies and autoimmune disorders. The company was founded by Christopher Huber, Özlem Türeci and Ugur Sahin in 2008 and is headquartered in Mainz, Germany.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Clinical Medicine Disease Immunology Infectious Diseases Drug Discovery Vaccines Autoimmunity Biomarkers Allergy In Vitro Autoimmune Disorders Immune Disorders Allergies Diagnostic Devices In Vitro Diagnostic Device
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Clinical Medicine Disease Immunology Infectious Diseases Drug Discovery Vaccines Autoimmunity Biomarkers Allergy In Vitro Autoimmune Disorders Immune Disorders Allergies Diagnostic Devices In Vitro Diagnostic Device
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 125.83 |
| 52 Week Low | 78.68 |
| Average Volume | 790,547 |
| 200-Day Moving Average | 96.60 |
| 50-Day Moving Average | 91.87 |
| 20-Day Moving Average | 91.40 |
| 10-Day Moving Average | 83.83 |
| Average True Range | 3.02 |
| RSI (14) | 28.06 |
| ADX | 27.51 |
| +DI | 15.96 |
| -DI | 38.83 |
| Chandelier Exit (Long, 3 ATRs) | 95.26 |
| Chandelier Exit (Short, 3 ATRs) | 87.75 |
| Upper Bollinger Bands | 107.74 |
| Lower Bollinger Band | 75.07 |
| Percent B (%b) | 0.12 |
| BandWidth | 35.74 |
| MACD Line | -3.97 |
| MACD Signal Line | -2.37 |
| MACD Histogram | -1.6043 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 83.63 | ||||
| Resistance 3 (R3) | 84.11 | 83.00 | 82.83 | ||
| Resistance 2 (R2) | 83.00 | 81.77 | 82.76 | 82.56 | |
| Resistance 1 (R1) | 80.91 | 81.02 | 80.36 | 80.43 | 82.30 |
| Pivot Point | 79.80 | 79.80 | 79.52 | 79.56 | 79.80 |
| Support 1 (S1) | 77.71 | 78.57 | 77.16 | 77.23 | 75.36 |
| Support 2 (S2) | 76.60 | 77.82 | 76.36 | 75.10 | |
| Support 3 (S3) | 74.51 | 76.60 | 74.83 | ||
| Support 4 (S4) | 74.03 |
